Alternatives for Injectable Diabetes Care Market to Hit US$ 10.28 Billion by 2031 | Exclusive Report by Growth Plus Reports

Newark, New Castle, USA, June 05, 2023 (GLOBE NEWSWIRE) — The market analysis of the global alternatives for injectable diabetes care market was conducted by Growth Plus Reports in 2022 and was valued at US$ 4.68 billion. The market is expected to hit a revenue CAGR of 9.3% to reach US$ 10.28 billion by 2031.

Analysis of the global market for alternatives for injectable diabetes care indicates that during the forecast period, revenue share is likely to increase significantly. The global Injectable Diabetes Care Market is witnessing the emergence of alternative solutions as patients seek convenient and less invasive options for diabetes management. With the growing prevalence of diabetes worldwide and the increasing demand for patient-centric care, a range of innovative alternatives to injectable therapies is gaining momentum. A recently published market research report offers a comprehensive analysis of the current trends, market drivers, challenges, and growth opportunities in the field of alternative solutions for injectable diabetes care.

Get a Free Sample Research Report: https://www.growthplusreports.com/inquiry/request-sample/alternatives-for-injectable-diabetes-care-market/8964

                    Alternatives for Injectable Diabetes Care Market Scope

Injectable therapies, such as insulin injections, have long been the cornerstone of diabetes management. However, factors such as fear of needles, injection site reactions, and the inconvenience of daily injections have driven the exploration of alternative options. Patients are now looking for alternatives that provide effective glucose control while offering convenience, ease of use, and improved quality of life.

The market research report highlights several alternative solutions gaining traction in the injectable diabetes care market. Firstly, oral medications and non-injectable formulations, such as tablets, capsules, and inhalable insulin, are being developed and commercialized to provide patients with more convenient options for glucose control. These alternatives aim to reduce the need for frequent injections and simplify the daily management of diabetes.

Secondly, advancements in technology have led to the development of wearable devices and continuous glucose monitoring (CGM) systems. These innovative solutions enable real-time monitoring of glucose levels, providing patients with valuable insights into their diabetes management. CGM systems offer a non-invasive method to track glucose levels and help patients make informed decisions regarding diet, exercise, and medication adjustments.

Furthermore, research is underway to explore the potential of closed-loop systems, also known as artificial pancreas systems, which combine continuous glucose monitoring and automated insulin delivery. These systems aim to mimic the function of a healthy pancreas by continuously monitoring glucose levels and delivering insulin as needed, reducing the need for manual injections and enhancing glucose control.

Request for Customization – https://www.growthplusreports.com/inquiry/customization/alternatives-for-injectable-diabetes-care-market/8964

Recent Development in the Alternatives for Injectable Diabetes Care Market: 

• In May 2022, The MiniMed 780G System was introduced in India by Medtronic India. The MiniMed 780G system is a cutting-edge closed-loop insulin pump device for the management of type 1 diabetes in patients between the ages of 7-80.

Competitive Landscape

A list of the prominent players operating in the global market for alternatives for injectable diabetes care includes: 

• Ypsomed AG
• Insulet Corporation
• F. Hoffmann-La Roche Ltd.
• Tandem Diabetic Care, Inc.
• Cellenovo 

Market Segmentation: 

Based on products, the global alternatives for the injectable diabetes care market are segmented into insulin pumps, inhaled insulin, insulin patches, and others.

The insulin pumps segment is sub-segmented into untethered insulin pumps, implantable insulin pumps, and tethered insulin pumps.

Based on end-user, the global alternatives for the injectable diabetes care market are segmented into hospitals, diabetes clinics, ambulatory surgical centers, and home care settings.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022) 
   3. Regulatory Landscape
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL ALTERNATIVES FOR INJECTABLE DIABETES CARE MARKET – ANALYSIS & FORECAST, BY PRODUCT
   1. Insulin Pumps
      1. Untethered Insulin Pumps
      2. Implantable Insulin Pumps
      3. Tethered Insulin Pumps
   2. Insulin Patches
   3. Inhaled Insulin
   4. Others
6. GLOBAL ALTERNATIVES FOR INJECTABLE DIABETES CARE MARKET – ANALYSIS & FORECAST, BY END USER
   1. Hospitals
   2. Diabetes Clinics
   3. Ambulatory Surgical Centers
   4. Homecare Settings

ALTERNATIVES FOR INJECTABLE DIABETES CARE MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8964

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market.

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Total Reflection X-Ray Fluorescence Spectrometer Market by Type (Portable, Multi-Element), Application (Food Industry, Pharmaceutical Industry) – Global Outlook & Forecast 2023-2031

Biologic Response Modifiers Market by Type (Monoclonal Antibodies, Interleukins), Application (Autoimmune Diseases, Cancer) – Global Outlook & Forecast 2023-2031

Medical Aesthetics Market by Type (Energy-Based Devices, Non-Energy Based Devices), Application (Body Contouring and Cellulite Reduction, Hair and Tattoo Removal), End User (Hospitals, Specialty Clinics, Others) – Global Outlook & Forecast 2023-2031

Anorectal Drugs Market by Indication (Dermatological Disorders, Hemorrhoids), Drug Class (Corticosteroids, Anti-infectives), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Nummular Eczema Treatment Market by Drug Class (Immunomodulators, Antibiotics, Antihistamines), Route of Administration (Topical, Oral, Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Global Outlook & Forecast 2023-2031

Unleashing the Power of Innovation in Med Tech https://growthplusmedtechroundup.com/

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020”.